Literature DB >> 32330112

Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.

Yi Luo, Edwin Trevathan, Zhengmin Qian, Yirong Li, Jin Li, Wei Xiao, Ning Tu, Zhikun Zeng, Pingzheng Mo, Yong Xiong, Guangming Ye.   

Abstract

We found that all 5 asymptomatic household contacts of a Wuhan, China, physician with coronavirus disease had severe acute respiratory syndrome coronavirus 2 detected by PCR. The index patient and 2 contacts also had abnormal chest computed tomography scans. Asymptomatic infected household contacts of healthcare workers with coronavirus disease might be underrecognized.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; China; SARS-CoV-2; Wuhan; asymptomatic; coronavirus disease; healthcare workers; household contacts; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32330112      PMCID: PMC7392452          DOI: 10.3201/eid2608.201016

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease (COVID-19) pandemic, is highly contagious and can put families of healthcare professionals at risk for both symptomatic COVID-19 and asymptomatic SARS-CoV-2 infection with potential to infect others (–). Data regarding asymptomatic SARS-CoV-2 infection () among families of healthcare professionals can help inform healthcare management and the public health response during the COVID-19 pandemic. We describe the case of a physician in Wuhan, China, who had mildly symptomatic COVID-19 and the subsequent asymptomatic SARS-CoV-2 infection in all 5 of his household contacts. The index patient (patient 1) was a 39-year-old nephrologist at Central Hospital of Wuhan who had onset of a dry cough on January 31, 2020, was admitted with fever on February 7, and was diagnosed with symptomatic SARS-CoV-2 infection on February 10. During January 31–February 6, patient 1 lived with 5 other immediate family members, all of whom were hospitalized on February 11 at Zhongnan Hospital of Wuhan University for ethics committee–approved (approval no. 2019125) medical studies, for which informed consent was obtained. The household contacts were his 37-year-old wife, a laboratory physician without patient contact at Zhongnan Hospital (contact 1); 7-year-old fraternal twins, who were in contact only with family because of school closure and social distancing (contacts 2 and 3); a retired 62-year-old grandfather, who was a current smoker in good health (contact 4); and a retired 64-year-old grandmother in good health (contact 5). All household contacts underwent chest computed tomography scans and throat swabs for quantitative real-time reverse transcription PCR (qRT-PCR) tests for SARS-CoV-2 nucleic acid, in addition to other routine laboratory examinations (Table). qRT-PCR tests on stool specimens of contacts 1, 2, and 3 were positive for SARS-CoV-2. Contact 1 also was positive for SARS-CoV-2 on qRT-PCR tests of multiple serial throat swab specimens but negative for SARS-CoV-2 on IgM and IgG tests.
Table

Summary of laboratory results of a SARS-CoV-2–positive patient and 5 asymptomatic household contacts, Wuhan, China*

Laboratory testReference rangePatient 1Contact 1Contact 2†Contact 3‡Contact 4Contact 5
C-reactive protein, mg/L0–1018.82.00.40.41.52.7
Leukocyte count, × 109 cells/L3.5–9.56.686.894.796.863.545.84
Lymphocyte ratio, %20–5017.7018.5045.5067.9034.6033.10
CD19+ absolute count/μL240–1317140147626767271299
ALT, U/L7–45451152016157
AST, U/L13–352114439241814
d-dimer, ng/mL0–50016189101>350015097

*ALT, alanine aminotransferase; AST, aspartate aminotransferase; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
†Contact 2 had 4 serial negative throat swabs for SARS-CoV-2, and negative influenza A, influenza B, respiratory syncytial virus, parainfluenza virus, adenoviridae, Epistein-Barr virus, cucumber mosaic virus, mycoplasma, and chlamydia results. He had elevated AST and ALT and was negative for hepatitis A, B, C, and E; he had no jaundice or gastrointestinal symptoms. His AST and ALT returned to normal after 9 days of treatment with glycyrrhizinate 50 mg 3 times daily and vitamin C (0.2 g 3×/d).
‡Contact 3 had an elevated D-dimer level without anemia, bleeding, or evidence of a coagulopathy. She received vitamin C (0.2 g 3 ×/d). After the SARS-CoV-2 nucleic acid (throat swab) test was negative, her D-dimer level returned to normal (111 ng/mL).

*ALT, alanine aminotransferase; AST, aspartate aminotransferase; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
†Contact 2 had 4 serial negative throat swabs for SARS-CoV-2, and negative influenza A, influenza B, respiratory syncytial virus, parainfluenza virus, adenoviridae, Epistein-Barr virus, cucumber mosaic virus, mycoplasma, and chlamydia results. He had elevated AST and ALT and was negative for hepatitis A, B, C, and E; he had no jaundice or gastrointestinal symptoms. His AST and ALT returned to normal after 9 days of treatment with glycyrrhizinate 50 mg 3 times daily and vitamin C (0.2 g 3×/d).
‡Contact 3 had an elevated D-dimer level without anemia, bleeding, or evidence of a coagulopathy. She received vitamin C (0.2 g 3 ×/d). After the SARS-CoV-2 nucleic acid (throat swab) test was negative, her D-dimer level returned to normal (111 ng/mL). All 5 household contacts of patient 1 had laboratory evidence of SARS-CoV-2 infection but remained asymptomatic throughout the period of observation (February 11–March 1) (Figure, panel A). All household contacts who had throat swab specimens tested for SARS-CoV-2 were positive by PCR except for contact 2, who tested negative on 4 consecutive throat swab specimen tests for SARS-CoV-2 but whose stool specimen was positive for SARS-CoV-2; contact 2 also had elevated liver enzymes but no jaundice. Contact 3 had an elevated D-dimer level. These abnormal laboratory values resolved during observation (Table) and were not associated with clinical illness in either patient. Patient 1 and contacts 2 and 4 also had abnormal chest computed tomography scans consistent with SARS-CoV-2 infection (Figure, panel B). Contact 1 underwent 11 serial throat swabs for SARS-CoV-2. Her case demonstrates the challenges of clinical interpretation qRT-PCR results for SARS-CoV-2. On 2 separate occasions, she had 2 consecutive negative results on throat swab specimens for SARS-CoV-2, only to revert back to having a throat swab specimen positive for SARS-CoV-2 (Figure, panel A). Contact 1 was the only family member who underwent serologic tests, which demonstrated low B lymphocyte counts but no detectable SARS-CoV-2–specific IgM or IgG. We cannot determine the cause or clinical significance of the lack of a detectable antibody response in contact 1 in our study, which differs from findings reported in other studies (). The immunologic response after asymptomatic SARS-CoV-2 infection requires further study.
Figure

Timeline and CT images associated with a cluster of SARS-CoV-2 infections in a single household, Wuhan China. A) Timeline of key events, including laboratory tests, associated with SARS-CoV-2 infections in the index patient and 5 asymptomatic household contacts. B) Abnormal chest CT scans showing features consistent with SARS-CoV-2 infection (arrows) observed in the index patient and 2 household contacts (top row), compared with normal CT scans among the 3 other household contacts (bottom row). CT, computed tomography; qRT-PCR, quantitative real-time reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Timeline and CT images associated with a cluster of SARS-CoV-2 infections in a single household, Wuhan China. A) Timeline of key events, including laboratory tests, associated with SARS-CoV-2 infections in the index patient and 5 asymptomatic household contacts. B) Abnormal chest CT scans showing features consistent with SARS-CoV-2 infection (arrows) observed in the index patient and 2 household contacts (top row), compared with normal CT scans among the 3 other household contacts (bottom row). CT, computed tomography; qRT-PCR, quantitative real-time reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. A likely source of infection for the 5 asymptomatic contacts was patient 1. Contact 1 had no patient contact and no known contact with COVID-19–positive co-workers, and contacts 2, 3, 4, and 5 were at their home in Wuhan and had no other substantial human contact during the period when they likely were infected. We identified no other likely source of infection. Our study could not determine the method of transmission between family contacts, but we did note the potential for respiratory transmission (e.g., through droplets), fecal–oral transmission, or both. An early report from China on 72,314 COVID-19 cases found that only 1% of SARS-CoV-2 infections were asymptomatic; however, asymptomatic close contacts were not routinely tested in that study (). In our study, all 5 household contacts of a physician diagnosed with COVID-19 had laboratory evidence of infection but remained asymptomatic. This finding is consistent with emerging evidence that suggests that a substantial proportion of SARS-CoV-2 infections are asymptomatic (,,). In summary, this single-household study found a high attack rate for asymptomatic SARS-CoV-2 infection among the immediate family members of a symptomatic COVID-19 case-patient. The extent to which asymptomatic SARS-CoV-2 infections contribute to overall disease transmission is still unknown and warrants further study. We believe the potential for fecal–oral transmission also warrants investigation (). Moreover, our experience indicates that screening symptomatic contacts with a single throat swab test for SARS-CoV-2 might lead to an underestimate of the rate of infection and that asymptomatic persons can repeatedly revert between positive and negative PCR results on throat specimens.
  10 in total

1.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.

Authors:  Yifei Chen; Liangjun Chen; Qiaoling Deng; Guqin Zhang; Kaisong Wu; Lan Ni; Yibin Yang; Bing Liu; Wei Wang; Chaojie Wei; Jiong Yang; Guangming Ye; Zhenshun Cheng
Journal:  J Med Virol       Date:  2020-04-25       Impact factor: 2.327

3.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.

Authors:  Zhiliang Hu; Ci Song; Chuanjun Xu; Guangfu Jin; Yaling Chen; Xin Xu; Hongxia Ma; Wei Chen; Yuan Lin; Yishan Zheng; Jianming Wang; Zhibin Hu; Yongxiang Yi; Hongbing Shen
Journal:  Sci China Life Sci       Date:  2020-03-04       Impact factor: 10.372

5.  Detection of antibodies against SARS-CoV-2 in patients with COVID-19.

Authors:  Zhe Du; Fengxue Zhu; Fuzheng Guo; Bo Yang; Tianbing Wang
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 2.327

6.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

Authors:  Desmond Sutton; Karin Fuchs; Mary D'Alton; Dena Goffman
Journal:  N Engl J Med       Date:  2020-04-13       Impact factor: 91.245

7.  Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.

Authors:  Feng Ye; Shicai Xu; Zhihua Rong; Ronghua Xu; Xiaowei Liu; Pingfu Deng; Hai Liu; Xuejun Xu
Journal:  Int J Infect Dis       Date:  2020-04-02       Impact factor: 3.623

8.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Takeshi Miyama; Ayako Suzuki; Sung-Mok Jung; Katsuma Hayashi; Ryo Kinoshita; Yichi Yang; Baoyin Yuan; Andrei R Akhmetzhanov; Natalie M Linton
Journal:  Int J Infect Dis       Date:  2020-03-14       Impact factor: 3.623

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

10.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
  10 in total
  26 in total

1.  Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study.

Authors:  Linwei Wang; Huiting Ma; Kristy C Y Yiu; Andrew Calzavara; David Landsman; Linh Luong; Adrienne K Chan; Rafal Kustra; Jeffrey C Kwong; Marie-Claude Boily; Stephen Hwang; Sharon Straus; Stefan D Baral; Sharmistha Mishra
Journal:  CMAJ Open       Date:  2020-10-09

2.  Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers.

Authors:  Mehool Patel; Meera Nair; Eric Pirozzoli; Marta C Cienfuegos; Elizabeth Aitken
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

3.  Asymptomatic Pre-Operative COVID-19 Screening for Essential and Elective Surgeries: Early Results of Universal Screening at a Midwestern Academic Medical Center.

Authors:  Nathan R Hendrickson; Kyle Kesler; David E DeMik; Natalie A Glass; Matthew K Watson; Bradley A Ford; Jorge L Salinas; Andrew J Pugely
Journal:  Iowa Orthop J       Date:  2021

4.  Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.

Authors:  P Galanis; D Kaitelidou; P Prezerakos; I Kotsiopoulos; O Siskou; O Konstantakopoulou; C Hadjichristodoulou; S Tsiodras
Journal:  Public Health       Date:  2021-07-31       Impact factor: 4.984

5.  An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic.

Authors:  Ryszard Targoński; Aleksandra Gąsecka; Adrian Prowancki; Radosław Targoński
Journal:  Med Hypotheses       Date:  2022-07-01       Impact factor: 4.411

6.  SARS-CoV-2 seroprevalence in healthcare workers: The experience of a Portuguese COVID-19 front-line hospital during the 1st pandemic wave.

Authors:  Angelica Ramos; Beatriz Araújo; Lisa Lacerda; Ana Lúcia Flora; Luis Ribeiro; Emília Patrício; Maria João Cardoso; João Tiago Guimarães
Journal:  Porto Biomed J       Date:  2022-06-17

7.  Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection.

Authors:  Swetha G Pinninti; Sunil Pati; Claudette Poole; Misty Latting; Maria C Seleme; April Yarbrough; Nitin Arora; William J Britt; Suresh Boppana
Journal:  Pediatrics       Date:  2021-02-23       Impact factor: 7.124

8.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.

Authors:  Johannes Korth; Benjamin Wilde; Sebastian Dolff; Olympia E Anastasiou; Adalbert Krawczyk; Michael Jahn; Sebastian Cordes; Birgit Ross; Stefan Esser; Monika Lindemann; Andreas Kribben; Ulf Dittmer; Oliver Witzke; Anke Herrmann
Journal:  J Clin Virol       Date:  2020-05-13       Impact factor: 3.168

9.  Paediatric Contacts of Adult COVID-19 Patients: Clinical Parameters, Risk Factors, and Outcome.

Authors:  Ammara Farooq; Taimur Khalil Sheikh; Fibhaa Syed; Tehmina Mustafa
Journal:  Int J Pediatr       Date:  2021-05-24

10.  SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.

Authors:  María Simón Sacristán; Carmen Ybarra de Villavicencio; Ana Collazos Blanco; María Elga Mayo Montero; María Del Carmen Ariñez Fernández; Adolfo Suárez Prieto; María Isabel Zamora Cintas; María Mateo Maestre
Journal:  Curr Microbiol       Date:  2021-06-22       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.